- Report
- January 2024
- 80 Pages
Germany
From €1326EUR$1,500USD£1,144GBP
- Report
- January 2024
- 80 Pages
India
From €1326EUR$1,500USD£1,144GBP
- Report
- January 2024
- 80 Pages
Russia
From €1326EUR$1,500USD£1,144GBP
- Report
- January 2024
- 80 Pages
Saudi Arabia
From €1326EUR$1,500USD£1,144GBP
- Report
- January 2024
- 80 Pages
South Korea
From €1326EUR$1,500USD£1,144GBP
- Report
- January 2024
- 80 Pages
United States
From €1326EUR$1,500USD£1,144GBP
- Report
- August 2022
- 96 Pages
Global
From €4416EUR$4,995USD£3,810GBP
- Report
- December 2023
- 70 Pages
Global
From €880EUR$995USD£759GBP
- Report
- December 2021
- 81 Pages
Global
From €3537EUR$4,000USD£3,051GBP
- Report
- January 2024
- 255 Pages
Global
From €2210EUR$2,500USD£1,907GBP
- Report
- January 2024
- 80 Pages
United Kingdom
From €1326EUR$1,500USD£1,144GBP
From €1326EUR$1,500USD£1,144GBP
- Report
- June 2025
- 80 Pages
From €3050EUR$3,450USD£2,631GBP
- Report
- June 2025
- 75 Pages
France
From €2166EUR$2,450USD£1,869GBP
- Report
- October 2024
- 70 Pages
China
From €840EUR$950USD£725GBP
- Report
- October 2024
- 70 Pages
France
From €840EUR$950USD£725GBP
- Report
- October 2024
- 70 Pages
Germany
From €840EUR$950USD£725GBP
- Report
- October 2024
- 70 Pages
India
From €840EUR$950USD£725GBP
- Report
- July 2024
- 243 Pages
China
From €3537EUR$4,000USD£3,051GBP
- Report
- June 2024
- 250 Pages
Global
From €4416EUR$4,995USD£3,810GBP

The biologic market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs. Biologic drugs are made from living organisms, such as proteins, nucleic acids, and cells, and are used to treat a variety of diseases. These drugs are typically more complex and expensive to produce than traditional small-molecule drugs. The biologic market is highly competitive, with many companies vying for market share.
The biologic market is divided into two main segments: therapeutic biologics and biosimilars. Therapeutic biologics are drugs that are developed to treat a specific disease or condition, while biosimilars are drugs that are similar to existing biologic drugs but are not identical.
Some of the major players in the biologic market include Amgen, Biogen, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development, production, and marketing of biologic drugs. Show Less Read more